CVKD - Cadrenal Therapeutics, Inc.

QQQ $ 604.92 $ 3.94 (0.66 %)

DIA $ 461.73 $ 2.22 (0.48 %)

SPY $ 665.28 $ 3.75 (0.57 %)

TLT $ 91.09 $ -0.14 (-0.15 %)

GLD $ 391.28 $ -7.46 (-1.88 %)

Previous Close

$ 13.63

Open

$ 13.61

Bid

$ 13.61 x 30

Ask

$ 14.40 x 1

Day's Range

$ 13.61 - $ 13.83

52 Week Range

$ 8.74 - $ 22.90

Volume

10,005

Average Volume

Market Cap

26.74M

Beta (5Y Monthly)

$ 4.42

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	08-11-2025	06-30-2025	10-Q
2	05-08-2025	03-31-2025	10-Q
3	03-13-2025	12-31-2024	10-K
4	11-07-2024	09-30-2024	10-Q
5	08-07-2024	06-30-2024	10-Q
6	05-09-2024	03-31-2024	10-Q
7	03-08-2024	12-31-2023	10-K
8	11-09-2023	09-30-2023	10-Q
9	08-10-2023	06-30-2023	10-Q
10	05-10-2023	03-31-2023	10-Q
11	03-30-2023	12-31-2022	10-K

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

12 Health Care Stocks Moving In Wednesday'...
09/17/2025 21:06:24

Cadrenal Acquires Assets Of eXIthera Pharm...
09/15/2025 12:04:31

Acquisition significantly enhances the Company's pipeline by adding novel assets in acute and chronic anticoagulation setti...

12 Health Care Stocks Moving In Wednesday'...
09/10/2025 21:06:05

Cadrenal Therapeutics Q2 EPS $(1.87) Misse...
08/11/2025 12:12:41

Cadrenal Therapeutics (NASDAQ:CVKD) reported quarterly losses of $(1.87) per share which missed the analyst consensus estimate ...

Cadrenal Therapeutics Announced Trial Init...
08/05/2025 10:07:26

12 Health Care Stocks Moving In Tuesday's ...
07/15/2025 12:07:58

12 Health Care Stocks Moving In Monday's P...
07/14/2025 12:08:12

Cadrenal Therapeutics Highlights Tecarfari...
06/12/2025 12:18:31

LVAD patients face a high risk of bleeding events associated with oral anticoagulation alongside increased risk of cardiovascul...

HC Wainwright & Co. Reiterates Buy on Cadr...
05/16/2025 10:47:21

HC Wainwright & Co. analyst Joseph Pantginis reiterates Cadrenal Therapeutics (NASDAQ:CVKD) with a Buy and maintains $32...

Cadrenal Therapeutics Announces Manufactur...
05/15/2025 11:35:10

Cadrenal Therapeutics, Inc. (NASDAQ:CVKD), a biopharmaceutical company developing therapeutics for patients with cardiovascular...

Cadrenal Therapeutics Q1 EPS $(2.09) Misse...
05/08/2025 12:13:02

Cadrenal Therapeutics (NASDAQ:CVKD) reported quarterly losses of $(2.09) per share which missed the analyst consensus estimate ...

Cadrenal Therapeutics FY 2024 GAAP EPS $(8...
03/13/2025 20:21:26

Cadrenal Therapeutics (NASDAQ:CVKD) reported quarterly losses of $(8.73) per share which missed the analyst consensus estimate ...

Cadrenal Therapeutics Announces Collaborat...
03/04/2025 13:06:06

Strengthens the Potential for Improved Patient Outcomes through Improvements in the Quality of Anticoagulation, Enhancing Hemoc...

Cadrenal Therapeutics Will Present At The ...
02/05/2025 14:06:13

Cadrenal Therapeutics Looks Ahead To 2025 ...
12/31/2024 13:10:36

12-health-care-stocks-moving-in-fridays-pre-market-session

12 Health Care Stocks Moving In Friday's P...
12/13/2024 21:06:04

HC Wainwright & Co. Maintains Buy on Cadre...
11/11/2024 17:57:48

HC Wainwright & Co. analyst Joseph Pantginis maintains Cadrenal Therapeutics (NASDAQ:CVKD) with a Buy, adjusts target to $3...

12-health-care-stocks-moving-in-mondays-intraday-session

12 Health Care Stocks Moving In Monday's I...
11/04/2024 16:40:00

Cadrenal Therapeutics Raises $5.1M Through...
10/24/2024 13:02:41

why-champions-oncology-shares-are-trading-higher-by-over-13-here-are-20-stocks-moving-premarket

Why Champions Oncology Shares Are Trading ...
09/12/2024 09:46:55